TCT 374: Redo Transcatheter Aortic Valve Replacement With the Novel DurAVR Valve: Insights From the Bench

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Grant Support/Research Contract - Edwards Lifesciences; Medtronic; Anteris; Heartflow
• Consultant Fee/Honoraria/Speaker's Bureau - Edwards Lifesciences; Medtronic; Anteris